Significantly improve quality of patients' lives through development of safe and effective endocannabinoid-based therapeutics.
To be the leaders in need-driven endocannabinoid system-based prescription medication development.
To develop proprietary endocannabinoid system-based prescription drugs for targeted diseases by regulating specific molecular mechanisms.
Medipure Pharmaceuticals is a biopharmaceutical company conducting pioneering research in prescription pharmaceuticals. We are specifically focused on developing and marketing these propriety therapeutics for targeted diseases.
- Pain Management
- Affective disorders
- Nausea and appetite
- Palliative care